Anti-CCR9 Chimeric Antigen Receptor T cells for T Cell Acute Lymphoblastic Leukemia

Scientists demonstrated that the chemokine receptor CCR9 is expressed in over 70% of cases of T-ALL, including over 85% or relapsed/ refractory disease, and only on a small fraction of normal T cells.